Troglitazone as a Novel Nrf2 Activator to Attenuate Oxidative Stress and Exert Neuroprotection
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00163 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Linjie Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Oxidative Stress, Troglitazone, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Science and Technology Program of Gansu Province, National Natural Science Foundation of China, Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
Nuclear factor erythroid 2 related factor 2 (Nrf2) is closely associated with neurodegenerative diseases, and the Nrf2-mediated activation of antioxidant response elements (AREs) brings about validated strategies for treating neurodegenerative diseases. Here, we discovered that troglitazone, a clinical medication for diabetes mellitus, could serve as a Nrf2 activator to rescue neuronal damages both in vitro and in vivo. The mechanism of troglitazone action involves binding with kelch-like ECH-associated protein 1 (Keap1) and the activation of Nrf2. This process leads to the migration of Nrf2 to the cell nucleus and transactivates the AREs. Troglitazone exhibits significant alleviation of oxidative stress in PC12 cells induced by hydrogen peroxide or 6-hydroxydopamine (6-OHDA). In vivo studies indicate that troglitazone could rescue the motor activity and neurodevelopmental deficiency in zebrafish induced by 6-OHDA. Additionally, mass spectrometry imaging demonstrates that troglitazone could cross the zebrafish blood-brain barrier, supporting the application of troglitazone in treating neurodegenerative diseases. Overall, this work reveals that the novel Nrf2 activator troglitazone has potential therapeutic value for neurodegeneration and provides a foundation for its repurposing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
- School of Life Sciences, Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, Lanzhou University, Lanzhou 730000, China.
- Center of Analysis and Testing, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
- School of Information Science and Engineering, Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Linjie Zhang, Junmin Xi, Jun Wu, Jianguo Fang, Haiyu Zhao, Baoxin Zhang
Förderung
- Science and Technology Program of Gansu Province
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province
Zitieren
APA
Zhang, L., Wang, S., Zhang, Y., Zhang, X., Xi, J., Wu, J., Fang, J., Zhao, H., & Zhang, B. (2025). Troglitazone as a Novel Nrf2 Activator to Attenuate Oxidative Stress and Exert Neuroprotection. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00163
Vancouver
Zhang L, Wang S, Zhang Y, Zhang X, Xi J, Wu J, et al. Troglitazone as a Novel Nrf2 Activator to Attenuate Oxidative Stress and Exert Neuroprotection. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00163
BibTeX
@article{Zhang2025,
author = {Zhang, Linjie and Wang, Shuang and Zhang, Yanxia and Zhang, Xiaopeng and Xi, Junmin and Wu, Jun and Fang, Jianguo and Zhao, Haiyu and Zhang, Baoxin},
title = {Troglitazone as a Novel Nrf2 Activator to Attenuate Oxidative Stress and Exert Neuroprotection},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00163}
}
EUVIMED